My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone (HGH)
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Livewell Pharmaceuticals Livewell Pharmaceuticals
Tirzepatide
Tirzepatide - Livewell Pharmaceuticals

Tirzepatide - Livewell Pharmaceuticals

Brand:
Livewell Pharmaceuticals
Category:
Peptides
Substance:
Tirzepatide
Package:
10 mg
Price:
$140.00 - $140.00
See options
Product Overview
Tirzepatide (Mounjaro®) by Eli Lilly is a first-in-class dual GIP and GLP-1 receptor agonist that addresses both glucose regulation and weight loss in Type 2 Diabetes. Approved in the U.S. and Europe in 2022, it has demonstrated superior outcomes in HbA1c reduction and body weight management compared to GLP-1 therapies. The SURPASS-4 trial also noted lower mortality in T2D patients on tirzepatide during COVID-19. Its unique profile opens the door to broader use in obesity and metabolic disease management.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tirzepatide by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.

Products
Active Substances
  • Tirzepatide
 About Product
Tirzepatide
Livewell Pharmaceuticals
USA
$140.00
Show more
Reviews
Leave Review
FAQ
What company makes Tirzepatide?
Tirzepatide is developed and marketed by Eli Lilly under the name Mounjaro®.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

How does Tirzepatide help with diabetes?
Tirzepatide works by activating GIP and GLP-1 receptors, which helps lower blood sugar and reduce appetite
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Is Tirzepatide safe for long-term use?
Clinical trials report Tirzepatide as generally well tolerated with a safety profile similar to GLP-1 drugs.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.